Clinical analysis of 20 cases of intravenous leiomyomatosis
Objective To summarize the clinical features,imaging features,treatment and prognosis of intravenous leiomyomatosis.Methods The clinicopathological data of 20 patients from the Affiliated Hospital of Jining Medical College from June 2022 to October 2023 were retrospectively analyzed. The imaging features of intravenously leiomyomatosis and the correlation between clinical features and recurrence risk were summarized,and the influencing factors of misdiagnosis and missed diagnosis were analyzed. Results The mean age of the patients was (45.8±3.2) years old. The imaging manifestations were mainly uterine enlargement,pelvic masses with venous occupation,and the clinical manifestations were related to the site of tumor involvement,8 patients (40%) had a history of uterine fibroids or hysteromyomectomy,and 2 patients (10%) were premenopausalm,all patients underwent surgical treatment and were pathologically confirmed as intravenous leiomyomatosis. One case ( 5%) was lost to follow-up,one case ( 5%) relapsed,and 18 cases (90%) had no recurrence and were still under follow-up. Conclusion The correct diagnosis of intravenous leiomyomatosis can only be made with the help of imaging combined with pathological gold standard,and the disease is prone to recurrence,surgery is the first choice for treatment,and regular follow-up is required after surgery.